What stage does Syno Capital, LLC invest at?

Syno Capital, LLC invests at the Series A stage.

What sectors does Syno Capital, LLC focus on?

Syno Capital, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Syno Capital, LLC located?

Syno Capital, LLC is headquartered in New York, US.

Syno Capital, LLC

Venture capital

New York · Series A · 4 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Syno Capital invests in building the next generation of healthcare companies, driven by a belief that progress comes only through innovation. The firm seeks out top talent globally to tackle the hardest problems in healthcare. Its approach is grounded in scientific and data-driven rigor, avoiding shortcuts in favor of thorough research. Investment decisions follow a disciplined process aimed at delivering strong returns based on a consistent risk-reward principle.

Invests inBiotech Digital Health Healthtech Medical Devices China Global New York New York City United States

Source: firm website, verified Aug 3, 2026.

Stage

Series A

New York, New York, US

Instruments

Equity

Founded

2015

Team · 4 people

from the firm's website & public directories

Dr. Xiang· Chief Investment Officer & Co-Founder

Co-founder and Chief Investment Officer of Syno Capital, with prior roles as a senior scientist at Schrodinger Inc. and on Genentech's medicinal chemistry team. He advises ZhongAn Insurance and Massachusetts General Hospital, has served on boards of biotech and healthcare companies, and holds a doctorate in Molecular Biophysics from Washington University Medical School.

Joseph Weilgus· Managing Director & Co-founder

Co-founder of Syno Capital and CEO of the New Legacy Group of Companies. Formerly president of Geller Holdings and a director at American Express Tax and Business Services; a CPA and founder of the children's non-profit Project Sunshine.

j•••@synocapital.comreveal

Justin Xiang· Chief Investment Officer & Co-founder

Co-founder and CIO of Syno Capital; a senior advisor to ZhongAn Insurance and member of Massachusetts General Hospital's International Advisory Council. Previously a senior scientist at Schrodinger Inc. and part of Genentech's medicinal chemistry team, with a PhD in molecular biophysics from Washington University.

j•••@synocapital.comreveal

Jake Rhyner· Senior Analyst

Joined Syno Capital in 2024, handling investment research, due diligence, and firm operations. Previously worked at early-stage startups in healthcare, medical device, and enterprise software; graduated from the University of Washington in finance.

j•••@synocapital.comreveal

Frequently asked questions

What stage does Syno Capital, LLC invest at?: Syno Capital, LLC invests at the Series A stage.
What sectors does Syno Capital, LLC focus on?: Syno Capital, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Syno Capital, LLC located?: Syno Capital, LLC is headquartered in New York, US.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M